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Available online 3 December 2018Background: The Iroquois homeobox 3 (Irx3) gene has been identified as a functional long-range target of obesity-
associated variants within the fat mass and obesity-associated protein (FTO) gene. It is highly expressed in the hy-
pothalamus, and bothwhole-body knockout and hypothalamic restricted abrogation of its expression results in a
lean phenotype, which is mostly explained by the resulting increased energy expenditure in the brown adipose
tissue. Because of its potential implication in the pathogenesis of obesity, we evaluated the hypothalamic cell dis-
tribution of Irx3 and the outcomes of inhibiting its expression in a rodent model of diet-induced obesity.
Methods: Bioinformatics toolswere used to evaluate the correlations betweenhypothalamic Irx3 andneurotrans-
mitters, markers of thermogenesis and obesity related phenotypes. Droplet-sequencing analysis in N20,000 hy-
pothalamic cells was used to explore the types of hypothalamic cells expressing Irx3. Lentivirus was used to
inhibit hypothalamic Irx3 and the resulting phenotype was studied.
Findings: IRX3 is expressed predominantly in POMC neurons. Its expression is inhibited during prolonged fasting,
aswell aswhenmice are fed a high-fat diet. The partial inhibition of hypothalamic Irx3 using a lentivirus resulted
in increased diet-induced body mass gain and adiposity due to increased caloric intake and reduced energy ex-
penditure.
Interpretation: Contrary to the results obtained when leanmice are submitted to complete inhibition of Irx3, par-
tial inhibition of hypothalamic Irx3 in obesemice causes an exacerbation of the obese phenotype. These data sug-
gest that at least some of the Irx3 functions in the hypothalamus are regulated according to a hormetic pattern,
and modulation of its expression can be a novel approach to modifying the body's energy-handling regulation.
Fund: Sao Paulo Research Foundation grants 2013/07607-8 (LAV) and 2017/02983-2 (JDJ); NIH grants
R01DK083567 (YBK).
© 2018 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Common genetic intronic variants of the fat mass and obesity-
associated gene (FTO) were identified in three independent studies as
being highly associated with the obese phenotype in the general popu-
lation [18,20,31]. At first, there were neither clues about the links be-
tween FTO intronic variants and changes in FTO function, nor evidence
of themechanisms by which humans carrying these variants would de-
velop abnormal body adiposity [37].ng, Obesity and Comorbidities
P), 13084-970 Campinas, SP,
o).
pen access article under the CC BY-NIn 2014, Smemo and coworkers showed that Iroquois homeobox 3
(Irx3) null mice were leaner than the controls due to a hypothalamic-
dependent increase in sympathetic tonus that stimulated brown adi-
pose tissue (BAT) activity and increased energy expenditure [33]. The
Irx3 gene is locatedwithin the Ft region, half of amegabase downstream
from the Fto gene [28]. Its promoter is regulated by long-range en-
hancers from the Fto intronic regions, providing the first evidence for
a connection between Fto and obesity through the regulation of Irx3
[33].
Specific subpopulations of hypothalamic neurons play central roles
in the control of body adiposity by regulating caloric intake and energy
expenditure [5,29,39]. Human and experimental data show that in obe-
sity, hypothalamic neurons are affected at the functional and structural
levels by an inflammatory response, triggered by the excessive con-
sumption of dietary fats ([17,23,26,27,34,35]; van de Sande-Lee et al.,C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Research in context
Evidence before this study
The fat mass and obesity-associated protein (FTO) gene has been
identified in a number of genome-wide association studies as one
of the most important genes linked to human obesity. However,
until recently, its actual role in obesity was unknown. In 2014,
the hypothalamic expression of Iroquois homeobox 3 (Irx3) gene
was shown to regulate energy expenditure through the control
of sympathetic outflow to the brown adipose tissue. It was also
demonstrated that Irx3 promoter is regulated by long-range en-
hancers from the Fto intronic regions, providing the first evidence
for a functional connection between Fto and obesity.
Added value of this study
Using single-cell RNA sequencing we demonstrate that hypotha-
lamic Irx3 is almost exclusively expressed in POMCneurons. In ad-
dition, we show that partial inhibition of hypothalamic Irx3 in adult
mice exacerbates the obese phenotype induced by a high-fat diet.
Themechanism underlying theworsening of the obese phenotype
is dependent on the reduction of brown adipose tissue thermo-
genic activity.
Implications of all the available evidence
POMC neurons are regarded as important potential targets for the
treatment of obesity. The identification of proteins that are
expressed in POMCneurons andplay important roles in the control
of whole body energy homeostasis may offer new opportunity for
the development of optimal strategies to treat obesity. In the hy-
pothalamus, Irx3 is almost exclusively present in POMC neurons
and controls brown adipose tissue function; thus, Irx3 emerges
as a potential target for the treatment of obesity.
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ronal function is a reduction of whole body energy expenditure, at
least in part due to the defective regulation of BAT thermogenesis
[6,30,32]. There are no previous studies investigating whether Irx3
expression is affected in diet-induced obesity, and if so, what the conse-
quences are of this abnormal regulation.
Here we show that hypothalamic Irx3 is down-regulated by
prolonged fasting and also by the consumption of a high-fat diet
(HFD). The hypothalamic inhibition of Irx3 results in increased body
mass gain due to increased caloric intake and reduced energy expendi-
ture, which is accompanied by reduced BAT thermogenesis. Thus, Irx3 is
abnormally regulated in diet-induced obesity, and further reducing its
hypothalamic levels results in increased body mass gain.2. Materials and methods
2.1. Animal models
Eight-week old male C57BL/6 J mice were employed in most of the
experiments, except for in some of the immunofluorescence determina-
tions, as described at the bottom of this paragraph. Mice were housed
individually; temperature was controlled (22 ± 1 °C), and a 12-hour
light–dark cycle was maintained. Food and water were available ad
libitum throughout the experimental period, except for during some ex-
periments designed to evaluate the effects of fasting and refeeding on
IRX3 expression, as detailed under study design. In order to determine
the expression of IRX3 in POMC andAgRP neurons in the hypothalamus,AgRP-Ires-Cre mice (Agrptm1(cre)Lowl/J, Jackson Laboratories) or POMC-
Cre mice (Tg(Pomc1-cre)16Lowl/J, Jackson Laboratories) were crossed
with Cre-inducible GFP-reporter mice (The Jackson Laboratory)
resulting in GFP expression specifically in AgRP or POMC neurons, re-
spectively. In addition, in another set of experiments aimed at detecting
IRX3 in POMC neurons in the solitary tract nucleus (NTS), POMC-Cre
mice (Tg(Pomc1-cre)16Lowl/J, Jackson Laboratories) were crossed with the
Cre-inducible GFP-reporter mouse (B6.129(Cg)-Tg(CAG-Bgeo/GFP)
21Lbe/J, The Jackson Laboratory). The mutations were confirmed by
genotyping (GoTaq® G2 Green Master Mix, Promega). All experiments
were performed in accordance with the guidelines of the Brazilian Col-
lege for Animal Experimentation and approved by the Institutional An-
imal Care and Use Committee (CEUA 3549-1).
2.2. Study design
For experiments involving the HFD, mice were randomly divided
into four groups and fed a HFD (55% calories from predominantly satu-
rated fat) for one day, three days, four weeks or eight weeks. The com-
position of diets is presented in Supplementary Table 1. Each groupwas
pairedwith a control group that was fed exclusively standard chow. For
the fasting experiment mice were fed standard chow or HFD for three
days, then fasted for 0, 3, 6 or 24 h. For knockdown experiments, mice
underwent stereotaxic surgery for a bilateral injection of lentiviral
shRNA scramble or IRX3 particles, then fed a HFD for four weeks.
2.3. Cell culture
The neuronal cell line mHypoA 2/29 CLU189 (CLU189) and the
microglial cell line BV2 were cultivated to 70% confluence in Dulbecco's
modified Eagle's medium (DMEM) containing 25 mM glucose and 10%
fetal bovine serum. cDNAs from both cell lines were used to analyze
the Irx3 gene expression by quantitative polymerase chain reaction
(qPCR).
2.4. Stereotaxic surgery
Commercially available (Sigma-Aldrich, St Louis, MO, USA) shRNA–
lentiviral clones to IRX3 TRCN 0000096101 (LV1), TRCN 0000096100
(LV2), TRCN 0000096099 (LV3), TRCN 00000423725 (LV4), TRCN
00000435053 (LV5) or scramble (SHC 016 V, pLKO.1-puro non-
mammalian shRNA control) (SCR) were used for knockdown experi-
ments. Mice were anesthetized with ketamine (100 mg/kg) and
xylazine (10 mg/kg) and submitted to stereotaxic surgery (Ultra
Precise–model 963, Kopf). Lentiviral shRNA particles (106 TU) were
injected bilaterally (1 μL/min) into the arcuate nucleus (ARC) (coordi-
nates [antero-posterior/lateral/depth to bregma]: 1.7/± 0.3/
−5.6 mm). The injection of Evan blue and dissection of the region of in-
terest provided the anatomical control of stereotaxic procedure (Suppl.
Fig. 1).
2.5. Indirect calorimetry and locomotor activity
Oxygen consumption (VO2), carbon dioxide production (VCO2), the
respiratory exchange ratio (RER), energy expenditure, and total loco-
motor activity were measured using an indirect open-circuit calorime-
ter (LE405 gas analyzer, Panlab/Harvard apparatus, Holliston, MA,
USA). Mice were allowed to adapt for 24 h before data were recorded
for 24 h (light and dark cycles). The feeding efficiency was calculated
as a ratio between total body mass gain (g) and cumulative energy in-
take (kcal) over 14 days, beginning after the stereotaxic surgery.
2.6. Heart perfusion and hypothalamic immunostaining
Mice were anesthetized with ketamine and xylazine, as previously
described, and perfused with an intracardiac infusion of 0.9% saline,
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dent, post-fixed for 24 h in 4% paraformaldehyde (PFA) solution, and
dehydrated in a buffer containing 20% sucrose at 4 °C. A series of 30
μm-thick frozen sections were prepared using a cryostat and stored in
an anti-freezing solution. For the immunostaining, slices were washed
twice with 0.1 M phosphate-buffered saline (PBS), then incubated in
0.25% Triton X-100 and 5% bovine serum albumin (BSA) in 0.1 M PBS
for 2 h at room temperature to block and permeablize. Slices were incu-
bated overnight at 4 °C with primary antibodies in a blocking solution.
After washing, sections were incubated with fluorophore-labeled sec-
ondary antibodies in a blocking solution for 2 h at room temperature.
The antibodies used are listed in Supplementary Table 2. Nuclei were la-
beled with 4′,6-diamidino-2-phenylindole (DAPI; #D9542; Sigma Al-
drich), and then mounted in Pro Long anti-fade fluorescence medium.Fig. 1. Irx3/IRX3 expression in mice and cells. The amount of Irx3 transcript in the heart ventric
cell-line CLU189 and the microglia cell-line BV2 (B). Immunofluorescence was employed to de
mice; inD, the yellowarrows indicate co-expression of POMC and IRX3. InA andB, results are exSections were visualized using a LEICA TCS SP5 II confocal laser-
scanning microscope (Leica Microsystems, Wetzlar, Germany).
2.7. Western blotting
For the immunoblot experiments, hypothalamus and brown adipose
tissue (BAT)were homogenized in approximately 10 volumes of solubi-
lization buffer containing 1% Triton X-100, 100 mM Tris (pH 7.4),
100 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM
EDTA, 10 mM sodium vanadate, 2 mM PMSF and 0.1 mg/mL aprotinin
at 4 °C in a “Polytron PTA 20S Generator” (Brinkmann Instruments
mode EN 10/35). The protein concentration of samples was determined
by the biuret reagent protein assay. One hundredmicrograms of protein
per samples was separated by SDS-PAGE and transferred tole and brain regions in mice was determined (A), as well as in the hypothalamic neuronal
termine the hypothalamic distribution of IRX3 in AgRP (C) and POMC (D) hrGFP-reporter
pressed asmean±SEM; n=5; inC andD, images are representative of three experiments.
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powder solution in TBST (1× TBS and 0.1% Tween 20) for 2 h,
washed twice with TBST, and incubated with primary antibodies
overnight at 4 °C. The antibodies used are listed in the Supplemen-
tary Table 2. HRP-coupled secondary antibodies were used for
detection of the conjugate by chemiluminescence, and visualization
was achieved by exposure to an Image Quant LAS4000 (GE
Healthcare, Life Sciences), using α-tubulin as loading control. Digital
quantification of band intensity was performed using Image J soft-
ware 1.48v (National Health).
2.8. RNA isolation and real-time quantitative polymerase chain reaction
(RT-qPCR)
The total RNA content was isolated from homogenized hypothala-
mus, hippocampus, frontal cortex, and occipital cortex, heart ventricles,
BAT or white adipose tissue (WAT) using TRIzol reagent (Invitrogen),
according to the manufacturer's recommendations. Two micrograms
of total RNA were reverse transcribed to cDNA, according to the manu-
facturer's instructions (High-Capacity cDNA Reverse Transcription Kit,
Life Technologies). Gene expression analyses via real-time quantitative
polymerase chain reaction (RT-qPCR) were performed using TaqMan
Universal PCR Master Mix (Life Technologies, Carlsbad, CA, USA). RT-
qPCR analyses of gene expression were carried out using an ABI Prism
7500 sequence detection system (Applied Biosystems). Primers pur-
chased from Applied Biosystems or Integrated DNA Technologies were
used to determine the expression of the endogenous gene glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) in all samples. All other
primers (and associated gene IDs) used are listed in Supplementary
Table 3. Real-time data were analyzed using the Sequence Detector Sys-
tem 1.7 (Applied Biosystems).
2.9. PCR array
Samples obtained from the hypothalamus of mice 28 days after the
bilateral injection of lentiviral vector were used to perform PCR array.
Gene expression determination was obtained with RT2 Profiler™ PCRFig. 2. IRX3 expression in the hypothalamus and solitary tract nucleus of mice. Immunofluoresc
nucleus (NTS, bottom panel) distribution of IRX3 in POMC GFP-reporter mice. In upper panel m
bottom panel merge, the inset shows high-magnification image of a cell that expresses POMCArray Mouse Inflammatory Cytokines & Receptors (PAMM-011Z,
Qiagen), a 96-gene panel that includes 84 genes for inflammatory cyto-
kines/receptors, along with genes for endogenous and positive controls
for the PCR reaction (Supplementary Table 4).2.10. Determination of interscapular brown adipose tissue (iBAT) and tail
temperature
In order to determine the interscapular brown adipose tissue (iBAT)
and tail thermal release, an infrared camera (IR) was used with an IR
resolution of 320 × 240 pixels and a thermal sensitivity and NETD of
b40mKat at 30 °C (FLIR T450sc, FLIR Systems, Inc.Wilsonville, USA). Im-
ages are presented in the rainbow high-contrast mode that is available
in the colour palette of the FLIR Tools software.2.11. Transmission electronic microscopy (TEM)
For ultrastructural analysis to the brown adipose tissue (BAT), the
animals were subjected to transcardiac perfusion with 0.1 M PBS
(20mL, pH 7.4), then fixedwith 2.5% glutaraldehyde in cacodilate buffer
0.1M (pH 7.2) and stored for 2 h at −4 °C. The specimens were post-
fixed with osmium in 0.2 M imidazol buffer (pH 7.5), dehydrated and
embedded in Durcupan ACS (Fluka, Steinheim, Switzerland). Ultrathin
cross sections were collected on formvar coated copper grids,
contrasted with uranyl acetate and lead citrate, and examined using a
Tecnai G2 Spirit Twin (FEI, Hillsboro, OR) transmission electron micro-
scope operated at 80 kV.2.12. Single cell RNA sequencing analysis (Drop-seq Analysis)
Bioinformatics analysis of IRX3 expression was performed using a
previously published [12] RNA sequencing library of 20,921 hypotha-
lamic arcuate andmedian eminence single cells. Heatmaps were gener-
ated using the library built-in user interface.ence was employed to determine the arcuate nucleus (ARC, upper panel) and solitary tract
erge, the inset shows high-magnification image of cells co-expressing POMC and IRX3. In
and not IRX3. Images are representative of three experiments.
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Correlation analyses were performed with data from hypothalamus
tissue samples with distinct phenotypes (BXD Published Phenotypes),
employing families of BXD inbred mice as published previously [3].
Row data are accessible on GeneNetwork. Heatmaps were created
using GENE-E (The Broad Institute, www.broadinstitute.org/cancer/
software/GENE-E/).
2.14. Statistical analysis
All results are reported as themean± SEM. Differences between the
treatment groupswere evaluated using an unpaired Student's t-test or a
one-way analysis of variance (ANOVA).When theANOVA indicated sig-
nificance, a Tukey-Kramer post-hoc test was performed (GraphPad
Software, San Diego, CA, USA). A p value b0.05 was considered
significant.
3. Results
3.1. Irx3 is expressed in POMC but not AgRP neurons in the hypothalamus
In agreement with a previous study [14], we confirmed that Irx3 is
highly expressed in the heart ventricle (Fig. 1A). In the brain, we
found considerable amounts of Irx3 transcripts, about half the amount
found in the heart, in all regions tested: hypothalamus, hippocampus,Fig. 3. Irx3 expression in a hypothalamic single-cell RNA sequencing library. The expression
hypothalamic arcuate nucleus and median eminence from mice, generated by Droplet-Seq
magnification view of the neuron clusters expressing highest levels of Irx3. In C, expression of
library built-in user interface.and occipital and frontal cortices (Fig. 1A). High expression of Irx3
was also detected in a hypothalamic neuronal cell-line (CLU189), but
not in a microglia cell-line (BV2) (Fig. 1B). Using AgRP (Fig. 1C) and
POMC (Fig. 1D) hrGFP-reporter mice, large numbers of Irx3 expressing
cells were identified in the median eminence and peri-ventricular re-
gion of the mediobasal hypothalamus. Co-localization was detected
with POMC, but not with AgRP neurons. In another set of experiments,
using another POMCGFP reportermice, the expression of IRX3was con-
firmed in hypothalamic POMC cells (Fig. 2, upper panel) but no IRX3
was detected in the POMC subpopulation in the NTS (Fig. 2, bottom
panel) [16]. In addition, bioinformatics analysis from a scRNA-seq li-
brary of hypothalamic arcuate and median eminence cell types identi-
fied high Irx3 expression in a few neurons (Fig. 3A–B). Two of these
expressed Pomc (Fig. 3B–C), whereas none expressed Agrp. In most of
the high Irx3 expressing cells there was an inverse relation between
transcript levels of Irx3 and Fto (Fig. 3A–C); this was particularly true
for Pomc neurons that expressed Irx3 (Fig. 3C). The graphic representa-
tion of Irx3 expression as determined in thedrop-seq analysis in all clus-
ters of cells and in neuron clusters are depicted in Suppl. Figs. 2 and 3,
respectively.
3.2. Hypothalamic Irx3 is regulated in response to a high-fat diet
Mice fed a HFD for one or three days (Fig. 4A–B), four weeks
(Fig. 4C–D) or eight weeks (Fig. 4E–F) presented with increased body
mass and reductions of Npy and Agrp after three days (Fig. 4B);of Irx3 was determined by scRNAseq analysis using a library of 20,921 single cells from
uencing (A-C). In A, Irx3 and Fto expression in single neurons and clusters. In B, high-
Irx3 and Fto in Pomc single cells. Data production and analysis were performed using the
453T.M. de Araujo et al. / EBioMedicine 39 (2019) 448–460increased POMC after four weeks (Fig. 4D), and reduction of Agrp after
eight weeks (Fig. 4F). No significant changes were found in hypotha-
lamic Cart at the time points tested. The hypothalamic expression of
Irx3 was reduced after three days, and after four and eight weeks on a
HFD (Fig. 4G). This was accompanied by increased expression of hypo-
thalamic Fto four and eight weeks after the introduction of a HFD
(Fig. 4H).Fig. 4.Modulation of hypothalamic Irx3 by a high-fat diet. Body mass variation of mice fed a h
analyses of hypothalamus of mice fed HFD at one or three days (B), four (D) and eight weeks (F
mice. In all experiments, except D, n = 5; in D, n = 9. In all experiments *p b 0.05 vs. respecti3.3. The consumption of a HFD disturbs the physiological pattern of regula-
tion of hypothalamic Irx3
Mice fed standard chow or a HFD for three days were submitted to a
protocol to determine the impact of fasting on the expression of hypo-
thalamic Irx3 (Fig. 5A). In mice fed standard chow (Fig. 5B), prolonged
fasting (24 h) resulted in the reduction of hypothalamic Irx3,igh-fat diet (HFD) after one or three days (A), four (C) and eight weeks (E). Neuropeptide
). Irx3 and Fto transcript expressions (G and H) during the same periods in A-F, in HFD fed
ve control (chow).
454 T.M. de Araujo et al. / EBioMedicine 39 (2019) 448–460accompanied by increased Npy and Agrp, with no changes in Pomc and
Cart. However, when mice were fed a HFD, the physiological regulation
pattern of Irx3 and the neurotransmitters were lost (Fig. 5C).
3.4. Inhibition of hypothalamic IRX3 results in body mass gain
We tested five distinct lentiviruses for inhibiting hypothalamic IRX3
(Fig. 6A). Lentivirus 5 (LV5) was the most efficient, resulting in approx-
imately 50% reduction of the IRX3 protein expression (Fig. 6A), andwas
the only one employed in the remaining experiments. After one day, the
hypothalamic inhibition of IRX3 in mice fed a HFD resulted in increased
caloric intake (Fig. 6B) and increased body mass (Fig. 6C–D). These pa-
rameters were analyzed again at the end of the fourth week of IRX3 in-
hibition and significantly higher body mass persisted (not shown).
There was no change in lean mass (Fig. 6E); however, there was aFig. 5. The effect of fasting on the hypothalamic expression o Irx3 and neuropeptides. Mice we
tissue extraction is indicated. Transcript expressions of Npy, Agrp, Pomc, Cart and Irx3 were
experiments, n = 5; *p b 0.05 vs. respective control (0 h fast). ZT0-ZT12, Zeitgeber time 0-12 hsignificant increase in fat mass (Fig. 6F), which was accompanied by
an increase in energy storage efficiency (Fig. 6G). Moreover, the inhi-
bition of hypothalamic IRX3, resulted in the abolition of the ability of
the HFD to increase O2 consumption (Fig. 6H) and CO2 production
(Fig. 6I), both in the dark and light phases, respectively. There was
also a reduction of respiratory quotient during the light phase in
mice fed a HFD (Fig. 6J). Inhibiting hypothalamic IRX3 resulted in in-
creased expression of hypothalamic Fto (Fig. 6L), a trend to increase
Npy (Fig. 6M), a significant increase in Agrp (Fig. 6N), no change in
Pomc (Fig. 6O), and an increase in Cart in mice fed a HFD, only
(Fig. 6P). In addition, the inhibition of IRX3 resulted in an increase
in the number of c-Fos positive cells in the paraventricular nucleus,
a reduction in the number of c-Fos positive cells in the lateral hypo-
thalamus and no change in c-Fos positive cells in the ventromedial hy-
pothalamus (Suppl. Fig. 4).re submitted to the fasting protocol as depicted in A; the light/dark cycle and the time of
determined in hypothalamic samples of mice fed chow (B) or a high-fat diet (C). In all
.
Fig. 6. Phenotype and hypothalamic gene expression in mice with IRX3 inhibition. Five distinct lentiviruses (LV1–LV5) were tested for their efficiency to inhibit the expression of
hypothalamic IRX3; the protein level of IRX3 was determined by immunoblot (A). Mice were subjected to a bilateral injection of lentivirus LV5 or a scramble lentivirus (SCR) in the
arcuate nucleus, and fed on chow or a high-fat diet (HFD) and the following parameters were evaluated: caloric intake (B), body mass gain (C–D), lean mass (E), fat mass (F),
efficiency to store energy (G), O2 consumption (H), CO2 production (I), respiratory quotient (RQ) (J), and the hypothalamic transcript expressions of Fto (L), Npy (M), Agrp (N), Pomc
(O) and Cart (P). In all experiments, except A and B, parameters were evaluated 28 days after lentivirus injection. In all experiments n = 6; *p b 0.05 vs. respective control, or as
indicated in the graph.
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456 T.M. de Araujo et al. / EBioMedicine 39 (2019) 448–4603.5. The inhibition of hypothalamic IRX3 increases the expression of inflam-
matory genes in the hypothalamus
Because the inhibition of IRX3 in the hypothalamus resulted in the
worsening of the obese phenotype in mice fed a HFD, we asked if in-
creased sign of inflammation in the hypothalamus could accompany
this outcome. In a PCR array that evaluated the expression of 84 inflam-
matory genes we detected a predominant increase in inflammatory
genes following the inhibition of IRX3 (Fig. 7A). Significant increases
were found in Spp1, Ccr6, Tnfsd11, Ccl8 and Ccl24 expression, whereas
significant decreases were found in Il2r and Osm (Fig. 7B). All genes an-
alyzed and the complete name of the genes is presented Supplementary
Table 4.3.6. The inhibition of hypothalamic IRX3 is accompanied by molecular,
structural and functional changes in the brown adipose tissue
Wehypothesized that part of the effect of hypothalamic IRX3 inhibi-
tion on increased body mass gain associated with reduced energy ex-
penditure could be due to impaired brown adipose tissue (BAT)
activity. In fact, the inhibition of hypothalamic IRX3 resulted in reduced
expression of BAT UCP1 in mice fed a HFD (Fig. 8A and B) and no
changes in the expression of BAT PGC1a (Fig. 8A and C) and cytochrome
C (Fig. 8A and D). In addition, inhibiting hypothalamic IRX3 resulted in
increased BAT beta-3 adrenergic receptor in mice fed standard chow,
and a trend towards a reduction in mice fed a HFD (Fig. 8A and E). The
total mass of BAT was not affected by the inhibition of hypothalamic
IRX3 (Fig. 8F); however, BAT temperature increased in mice fed stan-
dard chow and was unaffected in mice fed a HFD (Fig. 8G–H). There
were no changes in tail temperature (Suppl. Fig. 5). Transmission elec-
tron microscopy revealed that the amount and size of lipid droplets in-
creased in the BAT of mice subjected to hypothalamic IRX3 inhibition
(Fig. 8I). The inhibition of hypothalamic IRX3 also affected the expres-
sion of browning/beiging genes in white adipose tissue, resulting in
the reduction of UCP1 and TBX1 (Fig. 9A); there was also an increase
in the white adipose tissue TNFα (Fig. 9B) but no significant changes
in lipogenic protein transcripts such as PPARγ, SCD1 and SCD2 (Fig. 9C).Fig. 7. Expression of transcripts encoding inflammatory proteins in the hypothalamus ofmice w
(A). Genes with the highest and lowest expression change in the hypothalamus of IRX3-inhibite
(SCR) (B). Results are representative of three independent experiments. Ccl8, chemokine (C-C
interleukin 2 receptor; Osm, oncostatin M; Spp1, secreted phosphoprotein 1; Tnfsf11, tumor n3.7. Bioinformatics analyses support findings on phenotypic effect of IRX3
inhibition
Using a public databank containing genetic and phenotypic features
of BXD inbred mice, we sought to determine whether a variation in hy-
pothalamic expression of Irx3 would be accompanied by changes in
metabolically related hypothalamic neurotransmitter transcripts and
systemic phenotypes related to whole body energy homeostasis.
There was a 1.53-fold variation in hypothalamic Irx3 levels among the
evaluated mice families (Fig. 10A). Subsequently, a strong positive cor-
relation was seen between hypothalamic Irx3 and Cart or Pomc
(Fig. 10B), and no correlation of Irx3 with Npy or Agrp (Fig. 10B). In ad-
dition, there was a negative correlation between Irx3 and Fto in the hy-
pothalamus (Fig. 10B). The hypothalamic levels of Irx3 transcripts
strongly correlated with the protein levels of UCP1 in BAT (Fig. 10C,
upper panel) and with the whole body respiratory exchange ratio
(Fig. 10C, bottom panel). Conversely, hypothalamic Irx3 was inversely
correlated with body mass gain and adiposity (Fig. 10C, lower panel).
Fig. 10D depicts a summary network of the analyzed genes and
phenotypes.
4. Discussion
The main objective of this study was to explore the hypothesis that
hypothalamic IRX3 could be regulated by the consumption of a high-
fat diet, and therefore, that it plays a mechanistic role in the develop-
ment of diet-induced obesity. This rational was based on the fact that
knocking out the Irx3 gene in mice resulted in a lean phenotype due
to increased BAT-dependent energy expenditure [33]; however, little
was known about the role of Irx3 in obesity.
IRX3 was first identified as a member of the Drosophila Iroquois-
complex, which is a conserved family of homeobox genes present in
plants and animals [7,11]. Early studies provided evidence for the role
of IRX3 in neural and whole body embryonic development, particularly
in antero-posterior patterning and anatomical regionalization of limbs
[9,15]. It was also shown that IRX genes are involved in the develop-
ment of the heart [14], duringwhich IRX3 plays a critical role in the pre-
cise regulation of electrical impulse propagation [41]. In 2010, a study
showed that IRX3 could be related to type 2 diabetes and obesity [28];
however, it was only in 2014 that the actual nature of this associationith inhibited IRX3. Heat map illustrating the results of a PCR array for inflammatory genes
dmice fed a high-fat diet (HFD), compared tomice treatedwith a scramble lentivirus (LV)
motif) ligand 8; Ccl24, chemokine (C-C motif) ligand24; Ccr6, chemokine receptor 6; Il2r,
ecrosis factor superfamily member 11.
457T.M. de Araujo et al. / EBioMedicine 39 (2019) 448–460was defined [33]. Both whole-body knockout (KO)mice and thosewith
hypothalamic-specific dominant negative Irx3 developed lean body
phenotypes due to increased energy expenditure and activation of the
BAT thermogenic gene signature [33], suggesting that hypothalamic
IRX3 is involved in the sympathetic control of BAT function. Still, to
date little is known about the putative regulation of hypothalamic
IRX3 by dietary factors and obesity.Fig. 8.Brown adipose tissue changes inmicewith an inhibition of hypothalamic IRX3.Micewere
arcuate nucleus, and fed on chow or a high-fat diet (HFD); after 28 days parameters were eval
activated receptor gamma coactivator 1-alpha (PGC1α) (A and C), cytochrome C (Cyt C) (A
determined by immunoblot, employing α-tubulin as housekeeping protein. Brown adipose tis
of the brown adipose tissue were harvested and prepared for transmission electron microscop
three independent experiments.Developmental studies have shown that Irx3 is involved in the early
organization of the hypothalamus [13,25], and that the deletion of the
chromosome region that harbors the Irx3 gene, such as the one found
in the fused toes mouse mutant, leads to severe hypothalamic malfor-
mation [4]. However, no previous study has explored the anatomical
and cellular distribution of IRX3 in the hypothalamus. First, the present
study confirms high expression of Irx3 in the heart as previously dem-
onstrated [28]. In addition, its expression was also high in distinctsubjected to a bilateral injection of lentivirus LV5 (LV) or a scramble lentivirus (SCR) in the
uated. The expression of uncoupling protein 1 (UCP1) (A and B), peroxisome proliferator-
and D) and beta 3 adrenergic receptor (β3) (A and E) in the brown adipose tissue were
sue mass was determined (F), as well as interscapular temperature (G and H). Fragments
y (I). In A–E, n = 6, *p b 0.05; in F-H, n = 8; *p b 0.05; in I, images are representative of
Fig. 9.White adipose tissue changes inmicewith an inhibition of hypothalamic IRX3.Mice
were subjected to a bilateral injection of lentivirus LV5 (LV) or a scramble lentivirus (SCR)
in the arcuate nucleus, and fed on chow or a high-fat diet (HFD); after 28 days parameters
were evaluated in the white adipose tissue. Real-time PCR was employed to determine
transcript expressions of the browning/beiging markers, uncoupling protein 1 (UCP1),
zinc finger protein of the cerebellum 1 (ZIC1), T-box protein 1 (TBX1) and
transmembrane protein 26 (TMEM26) (A); the inflammatory cytokines, tumor necrosis
factor-alpha (TNFα), interleukin 1-beta (IL1β) and interleukin 6 (IL6) (B); and the
lipogenic proteins, peroxisome proliferator-activated receptor gamma (PPARG), stearoyl
Co-A desaturase 1 (SCD1), and stearoyl Co-A desaturase 2 (SCD2) (C). In all experiments
n = 6; *p b 0.05 vs. respective control or as demonstrated in the panel.
458 T.M. de Araujo et al. / EBioMedicine 39 (2019) 448–460areas of the brain, including the hypothalamus. In this particular region,
the expression seemed to occur predominantly in POMC neurons; both
in immunofluorescence experiments using POMC and AgRP reporter
mice, and in a drop-seq experiment that evaluated N20,000 hypotha-
lamic neurons, IRX3was only found in POMCneurons [12].We also per-
formed an additional set of experiments in order to evaluate if IRX3
could be also present in the lorcaserin-sensitive NTS POMC neurons
[16]. Using a different strategy to obtain POMC reporter mice, we con-
firmed the expression of IRX3 in hypothalamic but not in NTS POMC
neurons. Studies have shown that proper function of POMC neurons is
essential for body mass stability [2]. In a timely study [10], researchers
generated a reversible genetic model of early-onset hyperphagia and
obesity in rodents by selectively blocking the expression of the Pomc
gene in hypothalamic neurons. By doing so, the authors demonstrated
that the longer POMC expression was absent, the more difficult it was
to reestablish normal body mass after the reactivation of gene expres-
sion. Furthermore, it has been shown that POMC expression is affected
very early after the introduction of a HFD, and that distinct patterns of
POMC regulation of in mice exposed to a HFD can predict the obese-
resistant or the obese-propensity phenotypes [34]. Thus, should IRX3
impact the regulation of POMC, it could play an important role in
whole body energy homeostasis and metabolism.
To explore the potential regulation of IRX3 by dietary factors, mice
were exposed to prolonged fasting and to a HFD. It was clear that hypo-
thalamic IRX3 regulation changes in response to fasting and feeding in
such way that the longer the fasting period, the lower the Irx3 expres-
sion. When mice were fed a HFD, the physiological pattern of hypotha-
lamic Irx3 regulation was lost, suggesting that the consumption of
dietary fats could have a direct impact on Irx3 expression. In fact, the
HFD alonewas capable of reducing hypothalamic expression of Irx3 sig-
nificantly after three days, an outcome that persisted for at least eight
weeks. This is thefirst evidence that consumption of dietary fats can dis-
turb hypothalamic Irx3 expression.
It was previously shown that whole body KO of Irx3 or the expres-
sion of a dominant negative Irx3 in the hypothalamus resulted in lean-
ness and activation of BAT [33]. The majority of the experiments
performed in that study employed mice fed standard chow [33]. To
gain further insight into the potential involvement of hypothalamic
Irx3 in diet-induced obesity, we inhibited Irx3 in the hypothalamus
using a lentivirus and fed mice a HFD. To our surprise, dissimilar to
the results reported by Smemoet al. [33], the inhibition of hypothalamic
Irx3 resulted in increased gain in body mass due to increased adiposity.
Under hypothalamic Irx3 inhibition mice consumed more calories and
presented with attenuation of HFD-induced increase of whole body O2
consumption/CO2 production, suggesting a reduction of energy expen-
diture. This was further supported by an increase inweight gain per cal-
orie consumed, suggesting that hypothalamic inhibition of Irx3 in obese
mice resulted in improved storage efficiency of whole body energy. Fur-
thermore, the inhibition of hypothalamic Irx3 resulted in a reduction of
UCP1 expression in BAT and a trend towards a reduction of the beta-3
adrenergic receptor, which was accompanied by increased BAT adipos-
ity. Interestingly, only minor phenotypic changes occurred when hypo-
thalamic Irx3 was inhibited in mice fed standard chow.
The mechanism behind the changes in whole body energy homeo-
stasis seen in this mousemodel may be related to the effect of hypotha-
lamic IRX3 on the expression of Agrp and Fto; both genes significantly
increase when IRX3 is inhibited. The role of FTO in the control of energy
homeostasis and body mass is still controversial. Studies have shown
that FTO RNA demethylase activity is linked to the regulation of adipo-
genesis [40], dopamine circuitry in themidbrain [22] and the activation
of ghrelin to control the response to food cues [24]. However, it seems
that this control occurs in a dose dependent way [24], which may ex-
plain why studies have not been able to provide evidence of any corre-
lation between hypothalamic FTO expression and the magnitude of
obesity. Regarding AgRP, there is amore straightforward correlation be-
tween hypothalamic expression and body adiposity [1,21]. AgRP has animportant role in the regulation of both food intake and energy expen-
diture [1,21]. However, considering IRX3 is present mostly in POMC
neurons, why does its inhibition affect AgRP expression while having
only a minor effect on POMC? POMC neurons are known to be rapidly
and transiently regulated in response to fasting and feeding [34]; thus,
it could be argued that, despite the fact thatwe did not detect significant
changes in POMC, at certain points during the fasting-feeding cycle it
could be changed to promote a regulation of AgRP, as previously
shown [19,36]. Further studies are required to evaluate the short-term
effects of IRX3 regulation on POMC expression.
Lastly, bioinformaticswere employed to determine if different hypo-
thalamic transcript levels of Irx3 correlatedwith Fto and neurotransmit-
ters in the hypothalamus, and also with some phenotypic parameters
related to whole body energy expenditure. A similar approach was
459T.M. de Araujo et al. / EBioMedicine 39 (2019) 448–460used to characterize metabolic traits establishing a reliable systems ge-
netics method to study the correlation of transcript expression with
both genetic and phenotypic features [3]. There was 1.53-fold variation
in the hypothalamic levels of Irx3 transcript among the mouse families
that were evaluated in this study. This variation positively correlated
with Pomc, yet negatively correlated with Fto. Most importantly, hypo-
thalamic Irx3 positively correlated with BAT UCP1 and respiratory ex-
change ratio, and negatively correlated with body mass gain and
adiposity, which is in agreement with our experimental findings using
the lentivirus to inhibit hypothalamic IRX3.
This is only the second study evaluating the potential involvement of
hypothalamic IRX3 inwhole body energy homeostasis. Surprisingly, the
phenotype obtained when we inhibited hypothalamic IRX3 was oppo-
site to the one obtained in the study by Smemo et al. [33]. There are
two differences that could explain the divergent phenotypes: first,
both models employed by Smemo et al. [33] had any IRX3 expression
at all, whereas in our model, IRX3 was reduced by 50%; second, both
models employed by Smemo et al. [33] had a lack of IRX3 beginning at
the embryonic life stage, whereas we inhibited IRX3 during adulthood.
This could be an issue because studies have shown that IRX3 is impor-
tant for a number of aspects of neuronal development, including the ap-
propriate development of the hypothalamus [13,25]; thus, extended
structural and cellular evaluation of the hypothalamus of the mutants
could provide information to help gain an understanding of the differ-
ences between phenotypes. Concerning the differences in the amountFig. 10. Bioinformatics analysis of hypothalamic Irx3 in mouse reference families. Hypothalam
Heatmap depicting the hypothalamic levels of Irx3 in comparison with neurotransmitters an
tissue (BAT) UCP1 protein (C, upper panel) or the phenotypes of respiratory exchange r
hypothalamic transcripts evaluated in this analysis (D); green connectors define negative corrof hypothalamic IRX3 protein, it has been argued that IRX3 protein
levels operate in a hormetic fashion [8] to control hypothalamic func-
tion. In fact, in our bioinformatics analysis, despite the negative correla-
tion between hypothalamic Irx3 and bodymass gain, in the two families
with the highest hypothalamic Irx3 expression, body mass gain in-
creased, supporting a hormetic regulation of Irx3 actions. Studies
using transgenes to express different levels of IRX3 in the hypothalamus
could help solve this question.
In conclusion, hypothalamic IRX3 is modulated by fasting/feeding
cycles, and diet-induced obesity disturbs this cycle, keeping IRX3 levels
lower than the baseline. Further reduction of hypothalamic IRX3 in obe-
sity models intensifies the obese phenotype due to a higher caloric in-
take and reduced energy expenditure. This work provides additional
evidence for the important role played by hypothalamic IRX3 in the
control of whole body homeostasis.
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